Biovica International AB (publ) reported earnings results for the third quarter and nine months ended January 31, 2022. For the third quarter, the company reported sales was SEK 0.957 million compared to SEK 1.76 million a year ago. Revenue was SEK 2.04 million compared to SEK 2.09 million a year ago. Net loss was SEK 14.33 million compared to SEK 10.91 million a year ago. Basic loss per share from continuing operations was SEK 0.5 compared to SEK 0.38 a year ago. Diluted loss per share from continuing operations was SEK 0.5 compared to SEK 0.38 a year ago.
For the nine months, sales was SEK 3.14 million compared to SEK 4.68 million a year ago. Revenue was SEK 4.36 million compared to SEK 7.74 million a year ago. Net loss was SEK 40.95 million compared to SEK 27.49 million a year ago. Basic loss per share from continuing operations was SEK 1.44 compared to SEK 0.97 a year ago. Diluted loss per share from continuing operations was SEK 1.44 compared to SEK 0.97 a year ago.